Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy
Clinical trial NCT04394247 · COMPLETED
Trial details
- NCT number
- NCT04394247
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-30
- Primary completion
- 2020-12-31
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.